Back to Breakers

Florie Borel

joined in Mar 6, 2019

Postdoctoral Research Fellow at Horae Gene Therapy Center, University of Massachusetts Medical School, USA.

Borel has 1 break published.

Gene therapy and ALS: one step closer to the clinic

Amyotrophic lateral sclerosis (ALS) is a devastating disease that on average kills in only 3 to 5 years after diagnosis, and for which there is still no cure today. ALS patients have progressive muscle weakness, leading to gradual paralysis and difficulties breathing which will usually... click to read more

Florie Borel | Postdoctoral Research Fellow at Horae Gene Therapy Center, University of Massachusetts Medical School, USA

Christian Mueller | Associate Professor at Horae Gene Therapy Center; Department of Pediatrics, University of Massachusetts Medical School, USA

gene therapy

amyotrophic lateral sclerosis

motor neuron disease

Reading time 4 min

published on Mar 6, 2019

Editor's picks